Publicaciones en colaboración con investigadores/as de Hospital Miguel Servet (5)

2005

  1. Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer

    Annals of Oncology, Vol. 16, Núm. 4, pp. 597-601

2004

  1. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer

    Clinical Lung Cancer, Vol. 5, Núm. 6, pp. 360-365

  2. Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

    Clinical Cancer Research, Vol. 10, Núm. 4, pp. 1318-1325

2001

  1. Novel approaches in the treatment of non-small-cell lung cancer

    ONCOLOGY, Vol. 15, Núm. 3 SUPPL. 6, pp. 52-60

2000

  1. Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer

    Lung Cancer, Vol. 28, Núm. 2, pp. 97-107